Mannkind (MNKD) Liabilities and Shareholders Equity (2010 - 2026)

Mannkind (MNKD) reported Liabilities and Shareholders Equity of $744.4 million for Q1 2026, up 81.5% year-over-year from $410.1 million in Q1 2025, and down 6.03% quarter-over-quarter from $792.2 million in Q4 2025.

Mannkind (MNKD) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

Mannkind (MNKD) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $744.4 million in Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $744.4 million, up 81.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 billion (up 42.69% YoY), and the FY2025 annual result was $792.2 million, up 101.14% from the prior year.
  • Liabilities and Shareholders Equity eased to $744.4 million in Q1 2026 per MNKD's latest filing, from $792.2 million in the prior quarter.
  • Over five years, Liabilities and Shareholders Equity peaked at $792.2 million in Q4 2025 and troughed at $285.8 million in Q2 2022.
  • A 5-year average of $425.1 million and a median of $410.1 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity retreated 17.12% in 2024, then soared 101.14% in 2025.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $295.3 million in 2022, then surged by 60.93% to $475.2 million in 2023, then declined by 17.12% to $393.8 million in 2024, then soared by 101.14% to $792.2 million in 2025, then declined by 6.03% to $744.4 million in 2026.
  • Business Quant data shows MNKD's Liabilities and Shareholders Equity at $744.4 million in Q1 2026, $792.2 million in Q4 2025, and $494.6 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 37.37 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - 811.27 Mn
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 14.93 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 1.73 Bn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 23.64 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 33.89 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 12.81 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 26.48 Bn
9 Abivax 91.96 Bn 91.96 Bn - 640.56 Mn
10 Mannkind 1.21 Bn 1.08 Bn 82.66 Mn 744.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 744.40 Mn
Dec 31, 2025 792.18 Mn
Sep 30, 2025 494.64 Mn
Jun 30, 2025 411.70 Mn
Mar 31, 2025 410.14 Mn
Dec 31, 2024 393.84 Mn
Sep 30, 2024 464.20 Mn
Jun 30, 2024 443.84 Mn
Mar 31, 2024 480.88 Mn
Dec 31, 2023 475.20 Mn
Sep 30, 2023 320.33 Mn
Jun 30, 2023 313.42 Mn
Mar 31, 2023 298.14 Mn
Dec 31, 2022 295.28 Mn
Sep 30, 2022 293.84 Mn
Jun 30, 2022 285.80 Mn
Mar 31, 2022 308.32 Mn
Dec 31, 2021 321.16 Mn
Sep 30, 2021 238.21 Mn
Jun 30, 2021 252.79 Mn